[ Ссылка ]

A common medication may help some cancer patients live longer, new evidence suggests.

A new study found that aspirin taken after diagnosis might improve survival in patients with gastrointestinal (GI) cancers. But some experts are warning that it might be too soon to call aspirin a lifesaver for these patients.

Past research found that aspirin might increase survival time in patients with colorectal cancer, but this study of nearly 14,000 patients looked at other GI cancers, as well as colorectal cancer.

свернуть